AmoyDx(SZ:300685) Ge Long Hui A P P·2025-10-09 13:24Core Viewpoint - The company Aide Biological (300685.SZ) has signed a B-round capital increase agreement with Shenzhen Sailu Medical Technology Co., Ltd., investing 50 million yuan in cash, acquiring a 2.3810% stake in Sailu Medical [1] Group 1: Investment Details - Aide Biological's investment of 50 million yuan includes 55,701 yuan as registered capital for Sailu Medical, with the remainder allocated to capital reserves [1] - Following this investment, Aide Biological will hold a 2.3810% equity stake in Sailu Medical [1] Group 2: Company Profile of Sailu Medical - Sailu Medical is recognized as a national high-tech enterprise and a "specialized and innovative" small giant enterprise [1] - The company focuses on developing proprietary upstream sequencing platforms, super-resolution spatial omics platforms, and solid-phase gene chip detection platforms [1] - Sailu Medical has received several awards for its core technologies, including an excellent award at the National Disruptive Technology Innovation Competition and a gold award at the Greater Bay Area High-Value Patent Cultivation Competition [1] Group 3: Product and Technology Highlights - Sailu Medical holds over 110 authorized patents, with core products including various sequencing instruments and spatial omics solutions [1] - The SalusPro gene sequencer is set to receive its Class III medical device registration certificate in January 2025, utilizing reversible terminator sequencing technology for DNA and RNA sequencing from human samples [1]